2020
DOI: 10.1101/2020.05.13.20100222
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Silent Disease and Loss of Taste and Smell are Common Manifestations of SARS-COV-2 Infection in a Quarantine Facility: Saudi Arabia

Abstract: BACKGROUND The Coronavirus disease 2019 (COVID-19) outbreak in Saudi Arabia was first identified in a traveler from Al Qatif city, on March 2nd, 2020. The disease has quickly spread and reached multiple cities within a few weeks. In an attempt to limit the spread of COVID-19 in Saudi Arabia, the government has implemented strict regulations. Starting March 15th, all travelers coming back to the kingdom were tested for COVID-19 and were quarantined in a government-designated facility. The same rule was applied … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…The searches for studies about asymptomatic or pre-symptomatic SARS-CoV-2, on 25 March, 20 April and 10 June, resulted in 89, 230 and 688 records for screening (S1 Figure). In the first version of the review [7], 11 articles were eligible for inclusion [17-27], version 2 [8] identified another 26 eligible records [28-53], and version 3 identified another 61 eligible records [54-114]. After excluding four articles for which more recent data became available in a subsequent version [25,29,30,35], the total number of articles included was 94 (S1 Table) [17-24,26-28,31-34,36-114].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The searches for studies about asymptomatic or pre-symptomatic SARS-CoV-2, on 25 March, 20 April and 10 June, resulted in 89, 230 and 688 records for screening (S1 Figure). In the first version of the review [7], 11 articles were eligible for inclusion [17-27], version 2 [8] identified another 26 eligible records [28-53], and version 3 identified another 61 eligible records [54-114]. After excluding four articles for which more recent data became available in a subsequent version [25,29,30,35], the total number of articles included was 94 (S1 Table) [17-24,26-28,31-34,36-114].…”
Section: Resultsmentioning
confidence: 99%
“…We included 79 studies that reported empirical data about 6616 people with SARS-CoV-2 infection (1287 defined as having asymptomatic infection) [17,18,21-23,26-28,31,32,34,36,39-45,47-50,52-54,56-62,64,66-68,70-77,79-90,92-112,114] and one statistical modelling study [24] (Table 1). The sex distribution of the people with asymptomatic infection was reported in 41/79 studies and the median age was reported in 35/79 studies (Table 1).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The remaining studies, in hospital settings, included adult patients only (15 studies, n = 3,228) [27,39,45,52,53,56,57,64,80,83,89,92,103,107,114], children only (10 studies, n = 285) [40][41][42]59,84,87,98,99,104,106], or adults and children (10 studies, n = 1,518) [54,67,77,79,86,88,96,102,109,112] (Table 1, Fig 1). The types of hospital and clinical severity of patients differed, including settings in which anyone with SARS-CoV-2 infection was admitted for isolation and traditional hospitals.…”
Section: Plos Medicinementioning
confidence: 99%
“…in mild symptomatic COVID-19 patients. 9 Objective (psychophysical test) has been available in few studies only, though it is considered to be the gold standard for diagnosis of OD. 2,10,11 Moein et al reported that only 35% of their subjects were aware about their smell problem before doing objective test which indicate that self-reporting of the symptoms may be not enough and the incidence rate of OD is much higher than reported by the previous studies.…”
Section: Introductionmentioning
confidence: 99%